Retrospective evaluation of the neutrophil-to-lymphocyte ratio as a prognostic marker in cats with blunt trauma (2018-2021): 177 cases

被引:0
|
作者
Doulidis, Pavlos G. [1 ]
Vali, Yasamin [2 ]
Ramos, Caroline Frizzo [3 ]
Guija-de-Arespacochaga, Abigail [4 ]
机构
[1] Univ Vet Med Vienna, Dept Compan Anim & Horses, Div Small Anim Internal Med, Vienna, Austria
[2] Univ Vet Med, Diagnost Imaging, Vienna, Austria
[3] Univ Vet Med, Clin Unit Anesthesiol & Perioperat Intens Care, Vienna, Austria
[4] Univ Vet Med, Dept Pathobiol, Clin Pathol Platform, Vienna, Austria
关键词
feline; hematology; NLR; outcome; trauma severity score; HIGHRISE SYNDROME; DIAGNOSTIC-VALUE; DOGS; POPULATIONS; BIOMARKERS; MORTALITY; SYSTEM; SEVERITY; SCORE; NLR;
D O I
10.1111/vec.13414
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Objective: To investigate the utility of the neutrophil-to-lymphocyte ratio (NLR) as a prognostic marker in cats with blunt trauma. Design: Retrospective study from January 2018 to December 2021. Setting: University teaching hospital. Animals: Medical records of 177 cats admitted with blunt trauma were evaluated. History, clinical findings, blood cell count-based ratios, thoracic radiographs on presentation, and outcome were reviewed. The Animal Trauma Triage (ATT) score was assessed in each cat and classified as mild (1-3), moderate (4-7), and severe trauma (>= 8). Forty-eight healthy blood donor cats served as the control population. NLR, neutrophil counts, and lymphocyte counts were compared between cats with blunt trauma and controls, and among trauma patients. Interventions: None Measurements and Main Results: NLR, neutrophil counts, and lymphocyte counts significantly differ in cats with blunt trauma compared to controls (p < 0.001), and NLR was higher in patients with thoracic trauma (p = 0.044). Nonsurvivors had lower lymphocyte counts (p = 0.041), although those values do not appear to be clinically relevant. A significant increase in NLR was observed with increasing severity of trauma (p < 0.001). The NLR was not associated with the length of hospitalization, intensive care assistance, or mortality. Conclusion: NLR is a widely available diagnostic tool, which can be used in addition to ATT to assess trauma severity, although in our study it was not predictive of the outcome.
引用
收藏
页码:478 / 486
页数:9
相关论文
共 49 条
  • [41] Is admission neutrophil-to-lymphocyte ratio an outcome predictor in critically ill multiple trauma patients? A retrospective single-centre cross-sectional study
    Jabbari, Latife
    Azizkhani, Leila
    Rouzbin, Fereshte
    Salarpour, Elaheh
    Hayati, Saeed
    TRAUMA-ENGLAND, 2024,
  • [42] Neutrophil-to-lymphocyte ratio compared to N-terminal pro-brain natriuretic peptide as a prognostic marker of adverse events in elderly patients with chronic heart failure
    Yan, Wei
    Li, Rui-Jun
    Jia, Qian
    Mu, Yang
    Liu, Chun-Lei
    He, Kun-Lun
    JOURNAL OF GERIATRIC CARDIOLOGY, 2017, 14 (02) : 127 - 134
  • [43] Neutrophil-to-Lymphocyte Ratio and Prognostic Nutritional Index Are Predictors for Overall Survival after Primary Pancreatic Resection of Pancreatic Ductal Adenocarcinoma: A Single Centre Evaluation
    Hackner, Danilo
    Merkel, Susanne
    Weiss, Andreas
    Krautz, Christian
    Weber, Georg F.
    Gruetzmann, Robert
    Brunner, Maximilian
    CANCERS, 2024, 16 (16)
  • [44] Evaluation of prognostic value of neutrophil-to-lymphocyte ratio in patients with acute-on-chronic liver failure or severe liver injury from chronic HBV infection
    Sun, Jian
    Guo, Hongying
    Yu, Xueping
    Chen, Jingwen
    Zhu, Haoxiang
    Qi, Xun
    Zhang, Xueyun
    Han, Jiajia
    Liu, Xiaoqin
    Yang, Jianghua
    Wang, Jiefei
    Qian, Zhiping
    Huang, Yuxian
    Mao, Richeng
    Zhang, Jiming
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E670 - E680
  • [45] Utility of Preoperative Neutrophil/Lymphocyte Ratio as a New Objective Prognostic Tool in Endoscopically Treated Upper Tract Urothelial Carcinoma: A Retrospective Evaluation
    Antonucci, Michele
    Defidio, Lorenzo
    De Dominicis, Mauro
    Russo, Nicola
    Nacchia, Antonio
    Lombardo, Riccardo
    Patel, Anup
    JOURNAL OF ENDOUROLOGY, 2020, 34 (09) : 993 - 1000
  • [46] Neutrophil-to-Lymphocyte Ratio (NLR) Useful as a Cost-Effective Preliminary Prognostic Marker in ST-Elevation Myocardial Infarction (STEMI): An Observational Study From a Tertiary Care Hospital in Northeast India
    Sharma Sr, Dibya J.
    Nath, Hirak J.
    Batta, Akash
    Goala, Ashok K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)
  • [47] The combination of PD-L1 expression and the neutrophil-to-lymphocyte ratio as a prognostic factor of postoperative recurrence in non-small-cell lung cancer: a retrospective cohort study
    Samejima, Hironobu
    Kojima, Kensuke
    Fujiwara, Ayako
    Tokunaga, Toshiteru
    Okishio, Kyoichi
    Yoon, Hyungeun
    BMC CANCER, 2023, 23 (01)
  • [48] Neutrophil-to-lymphocyte ratio an inflammatory biomarker, and prognostic marker in heart failure, cardiovascular disease and chronic inflammatory diseases: New insights for a potential predictor of anti-cytokine therapy responsiveness
    Garcia-Escobar, Artemio
    Vera-Vera, Silvio
    Tebar-Marquez, Daniel
    Rivero-Santana, Borja
    Jurado-Roman, Alfonso
    Jimenez-Valero, Santiago
    Galeote, Guillermo
    Cabrera, Jose-Angel
    Moreno, Raill
    MICROVASCULAR RESEARCH, 2023, 150
  • [49] Prognostic Model of Baseline Medications plus Neutrophil-to-lymphocyte Ratio in Patients with Advanced Non-small-cell Lung Cancer Receiving Immune Checkpoint Inhibitor plus Platinum Doublet: A Multicenter Retrospective Study
    Nasu, Izumi
    Kondo, Masahiro
    Uozumi, Ryuji
    Takada, Shinya
    Nawata, Shuichi
    Iihara, Hirotoshi
    Okumura, Yohei
    Takemoto, Masashi
    Mino, Kozo
    Sasaki, Tadanori
    Hirose, Chiemi
    Aomori, Tohru
    Shimano, Rena
    Maeno, Ken
    Oizumi, Satoshi
    Kusumoto, Sojiro
    Ohno, Yasushi
    Ikemura, Shinnosuke
    Takai, Daiya
    Hara, Azusa
    Kawazoe, Hitoshi
    Nakamura, Tomonori
    JOURNAL OF CANCER, 2023, 14 (05): : 676 - 688